<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02543177</url>
  </required_header>
  <id_info>
    <org_study_id>14-088</org_study_id>
    <nct_id>NCT02543177</nct_id>
  </id_info>
  <brief_title>Optimised Procedure in Patients With NSTEMI and CKD</brief_title>
  <acronym>NSTEMI-CKD</acronym>
  <official_title>Optimised Procedure in Patients With an Acute Non-ST-segment Elevation Myocardial Infarction and Acute or Chronic Kidney Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RWTH Aachen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RWTH Aachen University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim of the study is the determination of the ideal timepoint for the treatment of patients
      with acute Non-ST-segment Elevation Myocardial Infarction (NSTEMI) and an acute or chronic
      kidney disease (CKD) with a GRACE score &lt; 140. It should be determine if a prompt coronary
      angiography or the protection of the kidneys from the used contrast agent is more important
      for the outcome of the patients. Additionally it will be investigated if the ischemic
      precondition can help to prevent heart damages.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      According to international guidelines a coronary angiography has to be performed within 72h
      for patients with (NSTEMI).

      Patients with a GRACE score &gt; 140 belong to the high risk group and the coronary angiography
      has to be performed within 24h.

      Until today for patients with a GRACE score &gt; 140 and an acute or chronic kidney disease
      (CKD) the best approach is not known even though up to 40% of all NESTMI patients belong to
      this population. CKD in connection with an NSTEMI is one predictor for short and long term
      mortality and serious bleeding as a complication of coronary angiography. Additionally
      patient with CKD are at risk to experience a contrast agent induced aggravation of the CKD
      right up to a kidney failure. The pre- and post treatment of the kidneys seem to reduce this
      risk. The irrigation of the kidneys up to 48h prior coronary angiography optimises the kidney
      function and buffers the aggravation of kidney function caused by fluid loss or abstention at
      home.

      Additionally the influence of ischemic precondition on one arm of the patient will be
      evaluated in this setting. First studies give a hint that the kidneys may be protected
      against the contrast agent of the following catheter examination by ischemic precondition.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    not enough patients recruited
  </why_stopped>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">January 2018</completion_date>
  <primary_completion_date type="Anticipated">January 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of coronary adverse events between the four groups</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">1</enrollment>
  <condition>Non-ST-segment Elevation Myocardial Infarction</condition>
  <condition>Chronic Kidney Disease</condition>
  <arm_group>
    <arm_group_label>group A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>direct coronary angiography</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>direct coronary angiography plus ischemic precondition</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>delayed coronary angiography; the kidneys will be irrigated prior to coronary angiography</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group D</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>delayed coronary angiography plus ischemic precondition; the kidneys will be irrigated prior to coronary angiography</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>coronary angiography</intervention_name>
    <arm_group_label>group A</arm_group_label>
    <arm_group_label>group B</arm_group_label>
    <arm_group_label>group C</arm_group_label>
    <arm_group_label>group D</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ischemic precondition</intervention_name>
    <description>four cycles of congestion and flow of blood in the arm of the patient for 5 minutes</description>
    <arm_group_label>group B</arm_group_label>
    <arm_group_label>group D</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>prior kidney irrigation</intervention_name>
    <arm_group_label>group C</arm_group_label>
    <arm_group_label>group D</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient with an acute NSTEMI

          -  patient with a GRACE score &lt; 140

          -  patient with an acute or a chronic kidney disease (stage 1 - 5)

          -  patient who agree with the randomized assignment to one of the study groups in written

          -  signed Informed content prior to study inclusion

          -  patient who are legally competent at the time of study inclusion

        Exclusion Criteria:

          -  pregnancy

          -  nursing women

          -  patient has been committed to an institution by legal or regulatory order

          -  Mental condition rendering the subject unable to understand the nature, scope and
             possible consequences of the study

          -  participation in a parallel clinical trial

          -  subjects who are in any state of dependency to the investigators
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Becker, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinic for Cardiology, Pneumology, Angiology and Internal Intensive Medicine (Medical Clinic I)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Prof. Dr. Michael Becker</name>
      <address>
        <city>Aachen</city>
        <state>NRW</state>
        <zip>52074</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Goldenberg I, Subirana I, Boyko V, Vila J, Elosua R, Permanyer-Miralda G, Ferreira-González I, Benderly M, Guetta V, Behar S, Marrugat J. Relation between renal function and outcomes in patients with non-ST-segment elevation acute coronary syndrome: real-world data from the European Public Health Outcome Research and Indicators Collection Project. Arch Intern Med. 2010 May 24;170(10):888-95. doi: 10.1001/archinternmed.2010.95.</citation>
    <PMID>20498417</PMID>
  </reference>
  <reference>
    <citation>Hasdai D, Behar S, Wallentin L, Danchin N, Gitt AK, Boersma E, Fioretti PM, Simoons ML, Battler A. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur Heart J. 2002 Aug;23(15):1190-201.</citation>
    <PMID>12127921</PMID>
  </reference>
  <reference>
    <citation>Brar SS, Aharonian V, Mansukhani P, Moore N, Shen AY, Jorgensen M, Dua A, Short L, Kane K. Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial. Lancet. 2014 May 24;383(9931):1814-23. doi: 10.1016/S0140-6736(14)60689-9.</citation>
    <PMID>24856027</PMID>
  </reference>
  <reference>
    <citation>Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, Caso P, Dudek D, Gielen S, Huber K, Ohman M, Petrie MC, Sonntag F, Uva MS, Storey RF, Wijns W, Zahger D; ESC Committee for Practice Guidelines. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2011 Dec;32(23):2999-3054. doi: 10.1093/eurheartj/ehr236. Epub 2011 Aug 26.</citation>
    <PMID>21873419</PMID>
  </reference>
  <reference>
    <citation>Szummer K, Lundman P, Jacobson SH, Schön S, Lindbäck J, Stenestrand U, Wallentin L, Jernberg T; SWEDEHEART. Relation between renal function, presentation, use of therapies and in-hospital complications in acute coronary syndrome: data from the SWEDEHEART register. J Intern Med. 2010 Jul;268(1):40-9. doi: 10.1111/j.1365-2796.2009.02204.x. Epub 2009 Dec 3.</citation>
    <PMID>20210836</PMID>
  </reference>
  <reference>
    <citation>Er F, Nia AM, Dopp H, Hellmich M, Dahlem KM, Caglayan E, Kubacki T, Benzing T, Erdmann E, Burst V, Gassanov N. Ischemic preconditioning for prevention of contrast medium-induced nephropathy: randomized pilot RenPro Trial (Renal Protection Trial). Circulation. 2012 Jul 17;126(3):296-303. doi: 10.1161/CIRCULATIONAHA.112.096370. Epub 2012 Jun 26.</citation>
    <PMID>22735306</PMID>
  </reference>
  <reference>
    <citation>Bae EH, Lim SY, Cho KH, Choi JS, Kim CS, Park JW, Ma SK, Jeong MH, Kim SW. GFR and cardiovascular outcomes after acute myocardial infarction: results from the Korea Acute Myocardial Infarction Registry. Am J Kidney Dis. 2012 Jun;59(6):795-802. doi: 10.1053/j.ajkd.2012.01.016. Epub 2012 Mar 23.</citation>
    <PMID>22445708</PMID>
  </reference>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 4, 2015</study_first_submitted>
  <study_first_submitted_qc>September 4, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 7, 2015</study_first_posted>
  <last_update_submitted>October 4, 2016</last_update_submitted>
  <last_update_submitted_qc>October 4, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 5, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>NSTEMI, CKD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

